logo
Select company
Select metric
$ -65.55MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
11
Sector
27
Industry
39
History
9
$ 3.04Close
$ 0.51 - $ 5.18 52-Week Range
Ticker Information

Ticker

PROK

Company Name

PROKIDNEY CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PROKIDNEY CORP - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PROK - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 6.13M$ -71.67M$ -65.55M
3/31/2025$ 5.93M$ -68.53M$ -62.6M
12/31/2024$ 5.43M$ -61.77M$ -56.34M
9/30/2024$ 5M$ -45.11M$ -40.1M
6/30/2024$ 4.52M$ -34.93M$ -30.4M
3/31/2024$ 4.12M$ -30.52M$ -26.39M
12/31/2023$ 3.85M$ -29.46M$ -25.61M
9/30/2023$ 3.5M$ -34.3M$ -30.8M
6/30/2023$ 4.74M$ -36.2M$ -31.47M
3/31/2023$ 3.16M$ -30.33M$ -27.17M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROKIDNEY CORP's latest trailing twelve months (TTM) EBITDA stands at $ -2.32M.
  • Over the past 5 years, PROKIDNEY CORP's average EBITDA has been $ -41.89M.
  • The median EBITDA for PROKIDNEY CORP during this period was $ -31.13M
  • PROKIDNEY CORP reached its highest EBITDA over the past 5 years at $ -2.32M.
  • The lowest EBITDA recorded by PROKIDNEY CORP in the same timeframe $ -103.89M

PROKIDNEY CORP's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
SEPN : SEPTERNA INC $ -84.31MMREO : MEREO BIOPHARMA GROUP PLC $ -49.23MABEO : ABEONA THERAPEUTICS INC $ 79.97MCRDF : CARDIFF ONCOLOGY INC $ -50.37MAVTX : AVALO THERAPEUTICS INC $ -47.9MBBOT : BRIDGEBIO ONCOLOGY THERAPEUTICS INC $ -106.07MCOYA : COYA THERAPEUTICS INC $ -21.03MMNMD : MIND MEDICINE (MINDMED) INC $ -110.19MSANA : SANA BIOTECHNOLOGY INC $ -227.17MERNA : ERNEXA THERAPEUTICS INC $ -37.86M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for PROKIDNEY CORP is calculated as follows: EBIT [ $ -2.32M ] + DepAmor [ $ 0 ]
(=) EBITDA [ $ -2.32M ]

PROK - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -103.89M

Minimum

Dec 31, 2022

$ -2.32M

Maximum

Dec 31, 2021

$ -41.89M

Average

$ -31.13M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.8M with a standard deviation of $ 166.97M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.8M
median$ 8.83M
std$ 166.97M